Profile
ALVO ZTS TAK HLN TEVA ITCI
Company Name Alvotech Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $2.76B $73.16B $47.84B $46.83B $19.50B $14.05B
Employees 1.01K 13.80K 49.28K 24.56K 37.00K 0.86K
CEO Robert Wessman Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
ALVO ZTS TAK HLN TEVA ITCI
Quant Rating Score 2 3 3 3 1 1
Quant Rating Sell Neutral Neutral Neutral Strong Sell Strong Sell
Trading
ALVO ZTS TAK HLN TEVA ITCI
Last Close $9.13 $157.23 $14.97 $10.5 $17 $131.87
High 52 $13.52 $196.48 $15.39 $11.41 $22.77 $131.91
Low 52 $7.8 $144.45 $12.89 $8.26 $12.82 $67.99
Price vs. 52 Week High -32.47 % -19.98 % -2.73 % -7.98 % -25.34 % -0.03 %
Price vs. 52 Week Low 17.05 % 8.85 % 16.14 % 27.12 % 32.61 % 93.95 %
Total Return
ALVO ZTS TAK HLN TEVA ITCI
1 Month Return -11.19 % -3.29 % 2.75 % -5.75 % 0.24 % 0 %
3 Month Return -21.23 % -3.43 % -0.33 % 4.48 % 8.35 % 0.14 %
6 Month Return -27.54 % -5.01 % 13.93 % 7.8 % -24.85 % 53.34 %
9 Month Return -19.56 % -19.32 % 2.18 % -0.85 % -4.17 % 80.13 %
YTD Return -30.99 % -3.5 % 13.07 % 10.06 % -22.87 % 57.89 %
1 Year Return -24.04 % -8 % 15.87 % 23.53 % 4.62 % 85.5 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALVO ZTS TAK HLN TEVA ITCI
Dividend Yield Percentage (TTM) - 1.13 % 4.52 % 0.01 % - -
Dividend Paid and Capex Coverage Ration (TTM) -1.97 % 2 % 1.65 % - 2.53 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 196 % 0.05 % - -
Payout Ratio (TTM) - 32.25 % 280.28 % - - -
Growth
ALVO ZTS TAK HLN TEVA ITCI
Asset Growth 28.56 % 0.76 % -9.55 % 87.69 %
Gross Profit Growth 538.44 % -0.19 % 5.47 % 44.88 %
Revenue Growth 435.56 % -0.61 % 4.4 % 46.62 %
Revenue 3 Year 55.32 % 19.01 % 1.52 % 556.51 %
Revenue 5 Year 1295.18 % 33.95 % -5.5 % 600974.32 %
Revenue 10 Year 1295.18 % 33.95 % -38.45 % 32663.23 %
EBIT Growth 87.51 % 13.52 % -169.63 % 26.77 %
Net Income Growth 57.98 % 37.46 % -193.2 % 46.54 %
Net Income 3 Yeari Growth Per Share 73.36 % 4.91 % -482.97 % 79.29 %
Net Income 5 Yeari Growth Per Share -0.47 % 122.63 % -58.26 % 72.95 %
Net Income 10 Yeari Growth Per Share -0.47 % 122.63 % -140.46 % 32.41 %
Operating Income Growth 119.63 % 10.52 % -169.98 % 26.77 %
Operating Cash Flow Growth (CFG) 24.13 % 9.57 % -8.85 % 41.08 %
Operating 3 Year CFG 87.89 % 71.6 % 52.26 % 77.79 %
Operating 5 Year CFG -143.24 % 196.04 % 123.59 % 69.4 %
Operating 10 Year CFG -143.24 % 196.04 % -81.66 % 10.87 %
EPS Growth 64.2 % 45.45 % -190 % 50.68 %
EPS Diluted Growth 64.2 % 45.45 % -190 % 50.68 %
Book Value Per Share 62.45 % -1.63 % -30.36 % 80.54 %
Share Holder 3 Year Equity Growth Per Share 64.5 % -37.97 % -49 % 116.52 %
Share Holder 5 Year Equity Growth Per Share - -40.16 % -62.86 % 215.14 %
Share Holder 10 Year Equity Growth Per Share - -40.16 % -82.6 % 164.65 %
Dividend Per Share Growth - 49.01 % - -
Dividend 3 Year Growth Per Share - -49.79 % - -
Dividend 5 Year Growth Per Share - -49.97 % -100 % -
Dividend 10 Year Growth Per Share - -49.97 % -100 % -
Debt Growth 10.67 % 6.83 % -10.29 % 0.25 %
Free Cash Flow Growth 18.07 % 16.27 % -11.05 % 40.95 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
ALVO ZTS TAK HLN TEVA ITCI
Gross Profit Margin TTM 60.59 % 70.2 % 54.7 % 61.52 % 49.17 % 91.63 %
Return on Assets TTM 7.75 % 17.86 % 0.76 % 4.2 % -3.35 % -5.46 %
Return on Equity TTM -23.2 % 51.32 % 1.48 % 8.73 % -21.38 % -7.4 %
Return on Capital Employed TTM 13.13 % 32.08 % 3.75 % 7.74 % 1.59 % -10.05 %
Net Income Per EBT TTM 95.57 % 78.79 % 61.12 % 75.5 % 246.36 % 100.64 %
EBT Per Ebit TTM 78.53 % 92.99 % 40.08 % 86.58 % -120.28 % 63.57 %
EBIT Per Revenue TTM 21.97 % 37.01 % 9.62 % 19.64 % 2.61 % -17.15 %
Cash Flow To Debt Ratio TTM -12.14 % 43.63 % 21.32 % - 7.47 % -430.93 %
Receivables Turnover TTM 2.56 6.82 6.32 5.9 4.91 4.09
Payables Turnover TTM 3.4 6.51 4.36 2.19 3.69 2.18
Inventory Turnover TTM 1.62 1.16 1.7 3.63 2.6 2.17
Fixed Asset Turnover TTM 138.47 % 253.65 % 232.78 % 584.75 % 332.7 % 4569.25 %
Asset Turnover TTM 47.02 % 65.87 % 32.15 % 32.73 % 43.25 % 49.79 %
Operating Cash Flow Per Share TTM -0.53 6.58 608.55 - 1.11 -0.71
Free Cash Flow Per Share TTM -0.8 5.1 443.26 - 0.67 -0.71
Cash Per Share TTM 13.71 % 384.5 % 24349.44 % 24.05 % 149.12 % 970.67 %
Operating Cash Flow Sales Ratio TTM -25.42 % 31.71 % 21.01 % - 7.62 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 150.88 % 77.45 % 72.84 % - 60.43 % 100.44 %
Cash Flow Coverage Ratios TTM -12.14 % 43.63 % 21.32 % - 7.47 % -430.93 %
Price To Free Cash Flows Ratio TTM -12.27 32.07 9.73 - 25.68 -191.12
Price To Operating Cash Flows Ratio TTM -17.25 24.98 7.13 - 15.4 -185.85
Price Cash Flow Ratio TTM -17.25 24.98 7.13 - 15.4 -185.85
Income Statement (TTM)
ALVO ZTS TAK HLN TEVA ITCI
Revenue $0.49B $9.26B $4263.76B $11.23B $16.54B $0.68B
Gross Profit $0.3B $6.54B $2832.26B $6.95B $8.06B $0.62B
Gross Profit Ratio 62.16% 70.62% 66.43% 61.85% 48.74% 91.63%
EBITDA $-0.03B $3.87B $874.6B $2.51B $0.72B $-0.12B
Net Income $-0.23B $2.49B $144.07B $1.44B $-1.64B $-0.07B
EPS Diluted -0.87 5.47 45.58 0.32 -1.45 -0.72
Balance Sheet (MRQ)
ALVO ZTS TAK HLN TEVA ITCI
Long Term Debt $1.15B $5.39B $5029.93B $8.54B $16.3B $0.01B
Total Liabilities $1.63B $9.47B $7834.79B $18.09B $33.61B $0.22B
Total Equity $-0.41B $4.77B $7274.01B $16.22B $5.72B $1.15B
Total Investments $0.02B $0B $445.7B $0.08B $0B $0.69B
Total Debt $1.19B $6.74B $4843.75B $10.1B $18.08B $0.02B
Total Assets $1.22B $14.24B $15108.79B $34.32B $39.33B $1.37B
Cash Flow Statement (TTM)
ALVO ZTS TAK HLN TEVA ITCI
Net Income $-0.23B $2.5B $144.07B $1.44B $-1.96B $-0.07B
Inventory $-0.05B $-0.04B $-115.74B $0.22B $0.17B $-0.01B
Dividends Paid $0B $-0.79B $-287.19B $-0.57B $0B $0B
Operating Cash Flow $-0.24B $2.95B $716.34B $2.3B $1.25B $-0.07B
Capital Expenditure $-0.06B $-0.66B $-480.73B $-0.25B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.255
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.43
ALIM Alimera Sciences, Inc. 5.54
ALVOW Alvotech 1.7
AMPH Amphastar Pharmaceuticals, Inc. 23.16
AMRX Amneal Pharmaceuticals, Inc. 8.12
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 65.72
APUS Apimeds Pharmaceuticals US, Inc 1.7183
AQST Aquestive Therapeutics, Inc. 3.255
ASRT Assertio Holdings, Inc. 0.6501
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 9.28
AYTU Aytu BioPharma, Inc. 2.07
ETFs With Exposure to ALVO
Ticker ETF Name Weight Percentage Price
VWO Vanguard Emerging Markets Stock Index Fund 0.01 49.445
IBB iShares Biotechnology ETF 0.11267 127.01
VEU Vanguard FTSE All-World ex-US Index Fund 0 66.765
VT Vanguard Total World Stock Index Fund 0 127.47
VXUS Vanguard Total Intl Stock Idx Fund 0 68.645
SCHE Schwab Emerging Markets Equity ETF 0.0118447 30.155
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 0.008 40.605
BIB ProShares Ultra Nasdaq Biotechnology 0.201872 45.87
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 79.32
DWAS Invesco DWA SmallCap Momentum ETF 0.199 84.615
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.12 30.76
PZW.TO Invesco FTSE RAFI Global Small-Mid ETF 0.002 36.91
SPAK Defiance Next Gen SPAC Derived ETF 0.14 14.63
IBBQ Invesco Nasdaq Biotechnology ETF 0.275 21.18
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.29519 5.268
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.29519 6.17
VTSNX Vanguard Total Intl Stock Idx Fund 0 145.88
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.29519 6.144
STXK Ea Series Trust - Strive 2000 ETF 0.05 30.485
VFWAX Vanguard FTSE All-World ex-US Index Fd Admiral 0 41.06
VEMAX Vanguard Emerging Markets Stock Index Fund Admiral Shares 0.01 40.66
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.29519 4.494
VTIAX Vanguard Total International Stock Index Fd Admiral 0 36.48
VTWAX Vanguard Total World Stock Index Fund Admiral Shares 0 44.7
VEMRX Vanguard Emerging Mkts Stock Idx InsPlus 0.01 102.84
VTWIX Vanguard Total World Stock Index I 0 257.67
VTPSX Vanguard Total Intl Stock Idx InstlPls 0 145.91
RFLR Innovator ETFs Trust 0.05 25.195
GLCR GlacierShares Nasdaq Iceland ETF 9.05 25.61
Unlock